- Writing Committee
- Summary
- 1.0 Introduction
- 2.0 Aims of TB treatment
- 3.0 Laboratory diagnosis
- 4.0 Type and duration of TB treatment
- 5.0 Drug/drug interactions (see Table 1 & 2)
- 6.0 Overlapping toxicity profiles of antiretroviral drugs with anti-tuberculosis therapy
- 7.0 Drug absorption
- 8.0 When to start HAART
- 9.0 Directly observed therapy (DOT)
- 10.0 Tuberculin skin testing
- 11.0 Chemo preventative therapy – HAART or antituberculosis drugs?
- 12.0 Management of relapse, treatment failure and drug resistance
- 13.0 Pregnancy and breastfeeding
- 14.0 Immune reconstitution inflammatory syndrome (IRIS) / paradoxical reactions
- 15.0 Prevention and control of transmission of HIV related tuberculosis
- 16.0 Death and clinico-pathological audit of HIV-associated tuberculosis
- 17.0 Tables
- 18.0 References
TB/HIV Co-infection (2005)
BHIVA treatment guidelines for TB/HIV infection
February 2005
AL Pozniak, RF Miller, MCI Lipman, A R Freedman, LP Ormerod, MA Johnson, S Collins and SB Lucas, on behalf of the BHIVA guidelines writing committee.
These draft guidelines for TB/HIV infection are posted to the BHIVA website as pdf file. An editorial commentary, plus minor proofing and referencing are still in preparation.
Please send all comments by email to:
Dr Anton Pozniak:
anton.pozniak@chelwest.nhs.uk
